Vertex Pharmaceuticals Incorporated (VRTX) — Business segments and KPIs
Revenue by business segment and geography for Vertex Pharmaceuticals Incorporated, with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| TRIKAFTA/KAFTRIO | 10.31B | 86.2% |
| ALYFTREK | 837.8M | 7.0% |
| Manufactured Product, Other | 820.1M | 6.9% |
| Revenue by region | ||
| UNITED STATES | 7.55B | 45.9% |
| Non-US | 5.45B | 33.1% |
| Europe | 3.46B | 21.0% |